0001213900-26-017282
SEC filingOn February 17, 2026, XTL Biopharmaceuticals Ltd. convened an Extraordinary General Meeting of Shareholders, which was adjourned due to lack of quorum and rescheduled for February 24, 2026 at 4:00 p.m. Israel time at the offices of Amit, Pollak, Matalon & Co. in Tel Aviv, Israel.